Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,355.50
Bid: 1,353.00
Ask: 1,354.50
Change: -7.50 (-0.55%)
Spread: 1.50 (0.111%)
Open: 1,369.00
High: 1,376.50
Low: 1,348.50
Prev. Close: 1,363.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RENEGOTIATION & EXTENSION - BORROWING ARRANGEMENTS

2 Mar 2009 07:00

RNS Number : 0733O
Persimmon PLC
02 March 2009
 



Persimmon PLC

2 March 2009

RENEGOTIATION AND EXTENSION OF BORROWING ARRANGEMENTS 

In the Trading Update on 8 January, Persimmon stated that it had commenced discussions for the planned refinancing of the Group's credit facilities. 

Persimmon now announces that it has successfully agreed new terms and conditions with its banking partners and private note holders for the amendment of its existing credit facilities. The full documentation is currently in the process of being finalised, and a further announcement will be made when it has been signed. We have also agreed terms for a new Forward Start Banking Facility of £322 million which matures on 31 March 2012. Taken together, we will have committed funding lines of £1,085 million at the outset, reducing to £560 million during 2011. 

 

As a result of the above, our estimated blended interest rate will be c. 6.4%, an increase of c. 2.8% on previous arrangements.

The covenants associated with these new facilities are appropriate for the current market conditions and our strategy of focusing on cash generation. These include cash flow based interest cover, minimum net worth and total gearing based measures

We expect these new facilities to provide ample headroom and support for the effective management of the business over the next few years.

For further information, please contact:

Persimmon plc +44 (0) 1904 642 199

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

M: Communications

Edward Orlebar: +44 (0) 207 153 1523 / +44 (0) 7738 724 630

Charlotte McMullen: +44 (0) 207 153 1549 / +44 (0) 7921 881 800

Marylene Guernier +44 (0) 207 153 1269 / +44 (0) 7776 303 788

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEUFWWSUSESE
Date   Source Headline
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.